Eutropics_logo eutropics_tagline  


Michael Cardone, PhD
Co-founder, President and CEO
Michael Cardone leads the company’s efforts to achieve scientific and corporate milestones. His experience includes over 12 years of scientific and business management at early to mid-stage biotech companies, working with founding teams to develop operating plans, IP portfolios, and building next level operating teams. Prior to Eutropics he was a scientific co-founder of Merrimack Pharmaceuticals, a Cambridge, MA based company (NASDQ trading symbol: MACK) where he worked to develop the initial oncology program and recruit the starting team. Prior to this he lead a research team at the MIT department of Biology. Michael Cardone received an undergraduate degree in Biology from SFSU, San Francisco, CA; a PhD in Cell Biology from the University of California San Francisco. He completed post-doctoral studies at the Burnham Institute in La Jolla, CA, where he studied apoptosis signaling


William E. Pierceall, PhD
Director of Oncology
Bill Pierceall is leading the diagnostic development efforts at Eutropics. He has 15 years of experience as a technical leader in oncology and personalized medicine with emphasis on biomarker utilization in target-based drug discovery and novel diagnostic technology development. Dr. Pierceall’s background includes science leadership positions at Exact Sciences, Helicos Biosciences, Cetek Pharmaceuticals, and more recently at On-Q-ity where he managed strategic alliances and lead technical management in prosecution of intellectual property, including in circulating tumor cell characterization and diagnostics development. His undergraduate degree in biology is from the University of Illinois-Champaign-Urbana. He has an MS from the University of Missouri-Columbia and a PhD from University of Texas –Health Science Center-Houston. He completed post-doctoral studies in molecular oncology at Yale.





2010 Eutropics Pharmaceuticals. All rights reserved. | Site by Nette Gaastra